| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| APG115 | Small molecule | none | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | ['Recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Recruiting'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| CENERSEN | Oligonucleotide | none | p53 mRNA antisense inhibitor | 2 | ['Terminated', 'Withdrawn', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| CENERSEN SODIUM | Oligonucleotide | none | p53 mRNA antisense inhibitor | 2 | ['Terminated'] | ['ClinicalTrials'] |
| CONTUSUGENE LADENOVEC | Gene | none | Cellular tumor antigen p53 positive modulator | 4 | ['Completed', 'Unknown status', 'Terminated', 'Unknown status', 'Completed', 'Completed', 'Unknown status', 'Completed', 'Completed', 'Terminated', 'Completed', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| EPRENETAPOPT | Small molecule | none | Cellular tumor antigen p53 stabiliser | 3 | ['Completed', 'Completed', 'Completed', 'Completed', 'Terminated', 'Withdrawn', 'Terminated'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| IDASANUTLIN | Small molecule | none | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 3 | ['Terminated', 'Terminated', 'Terminated', 'Active, not recruiting', 'Terminated', 'Completed', 'Terminated', 'Terminated', 'Terminated', 'Recruiting', 'Completed', 'Terminated', 'Completed', 'Completed', 'Recruiting'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| NAVTEMADLIN | Small molecule | none | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | ['Recruiting', 'Active, not recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', 'Recruiting', 'Suspended', 'Recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Suspended'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| SIREMADLIN | Small molecule | none | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | ['Recruiting', 'Active, not recruiting', 'Withdrawn', 'Recruiting', 'Not yet recruiting', 'Completed', 'Completed', 'Terminated', 'Not yet recruiting', 'Terminated', 'Recruiting'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| TEPRASIRAN | Oligonucleotide | none | p53 mRNA RNAi inhibitor | 2 | ['Terminated', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials'] |
Showing 1 to 9 of 9 entries